Liver venous deprivation (LVD) or ALPPS in the treatment of colorectal liver metastasis (CRLM): a comparison of oncological outcome.

Date publication

novembre 2025

Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association

Auteurs

Membres identifiés du Cancéropôle Est :
Pr AYAV Ahmet

Tous les auteurs :
Boubaddi M, Rhaiem R, Pecquenard F, Buc E, Muscari F, Dokmak S, El Amrani M, Ayav A, Chebaro A, Sulpice L, Adam R, Laurent C, Truant S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41469244

Résumé

Patients with a high metastatic tumor burden may be candidates for extensive liver resection with a liver augmentation technique. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and liver venous deprivation (LVD) are the most effective techniques for stimulating liver growth. However, postoperative and oncological outcomes of these approaches require further clarification in large cohorts. This study assessed the oncological outcomes of patients treated for colorectal liver metastases (CRLM) using ALPPS or LVD.

Référence

HPB (Oxford). 2025 11 21;: